Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Screener

GCTK

GlucoTrack Inc

May 17 • 04:00PM ET

0.5000

Dollar change +0.0098
Percentage change 2.00	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.38	Insider Own	32.47%	Shs Outstand	20.89M	Perf Week	-10.75%
Market Cap	13.70M	Forward P/E	-	EPS next Y	-	Insider Trans	2.10%	Shs Float	18.50M	Perf Month	-25.37%
Income	-8.74M	PEG	-	EPS next Q	-	Inst Own	2.93%	Short Float	0.41%	Perf Quarter	108.33%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	17.58%	Short Ratio	0.37	Perf Half Y	198.69%
Book/sh	0.02	P/B	29.46	EPS next Y	-	ROA	-509.50%	Short Interest	0.08M	Perf Year	9.29%
Cash/sh	0.05	P/C	9.13	EPS next 5Y	-	ROE	-3799.13%	52W Range	0.13 - 0.99	Perf YTD	91.20%
Dividend Est.	-	P/FCF	-	EPS past 5Y	63.80%	ROI	-1244.73%	52W High	-49.49%	Beta	0.14
Dividend TTM	-	Quick Ratio	1.31	Sales past 5Y	55.66%	Gross Margin	-	52W Low	276.51%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	1.31	EPS Y/Y TTM	-28.51%	Oper. Margin	0.00%	RSI (14)	47.24	Volatility	12.29% 17.85%
Employees	6	Debt/Eq	0.60	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.56	EPS Q/Q	-41.33%	Payout	-	Rel Volume	0.33	Prev Close	0.49
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	203.90K	Price	0.50
SMA20	-15.14%	SMA50	6.62%	SMA200	67.19%	Trades		Volume	67,566	Change	2.00%

May-17-24 02:52PM	GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 (InvestorPlace)
May-16-24 08:30AM	GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY (GlobeNewswire)
May-15-24 04:15PM	GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT (GlobeNewswire) -10.20%
May-02-24 09:00AM	GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION (GlobeNewswire)
Apr-29-24 07:33AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +23.00%
02:18AM	Loading…
Apr-25-24 02:18AM	Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK) (GuruFocus.com)
Apr-22-24 02:10PM	GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT (GlobeNewswire) +9.88%
Apr-16-24 08:30AM	GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING (GlobeNewswire) +24.93%
Apr-03-24 07:00AM	Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now (GlobeNewswire) +13.33%
Apr-02-24 08:30AM	GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +7.46%
07:00AM	Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now (GlobeNewswire)
Mar-12-24 09:30AM	GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY (GlobeNewswire)
Feb-27-24 08:30AM	GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +13.78%
Feb-13-24 09:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAV TO CHAIR OF THE BOARD OF DIRECTORS (GlobeNewswire) -10.79%
Feb-07-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now (GlobeNewswire) +6.28%
07:00AM	Loading…
Feb-06-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now (GlobeNewswire)
Jan-10-24 07:00AM	Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream (GlobeNewswire)
Jan-09-24 07:00AM	Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now (GlobeNewswire)
Jan-02-24 12:33PM	GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) +8.95%
Nov-30-23 05:39PM	GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT (GlobeNewswire) +7.31%
Nov-13-23 09:00AM	GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE (GlobeNewswire)
Oct-12-23 08:30AM	GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) -20.65%
Aug-31-23 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS (GlobeNewswire)
Aug-28-23 09:00AM	GLUCOTRACK ANNOUNCES NEW VP OF MARKETING (GlobeNewswire)
Jul-26-23 02:30PM	The Power Play by The Market Herald Releases New Interviews with GlucoTrack and Acceleware Discussing Their Latest News (ACCESSWIRE) -7.95%
Jul-25-23 09:00AM	GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire)
Apr-17-23 11:05AM	Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ: GCTK) (ACCESSWIRE) -7.39%
09:15AM	GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Apr-13-23 09:22AM	GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -49.26%
Apr-12-23 05:50PM	GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock (GlobeNewswire) +37.76%
10:00AM	Loading…
Mar-14-23 10:00AM	GLUCOTRACK PROVIDES SHAREHOLDER UPDATE (GlobeNewswire) +16.94%

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SYCOFF DREW	Director	Apr 22 '24	Buy	1.26	182,540	230,000	2,951,258	Apr 24 06:31 PM

GCTK

GlucoTrack Inc

Upgrade your FINVIZ experience